Odyssean »

Gentex Corporation shares owned by Odyssean

Quarter-by-quarter ownership of Gentex Corporation (GNTX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Gentex Corporation

Tip: Access up to 7 years of quarterly data

All positions including Gentex Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gentex Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $789k 31k 25.27

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Gentex Corporation

Xxec
BlackRock
American Century Companies
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
Ariel Investments
Bank Of Montreal
Hanna Zanoni
State Street Corporation
Geode Capital Management
Robeco Investment Management
Disciplined Growth Investors
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership

View all funds holding Gentex Corporation